142 материалов по теме, собраны автоматически из проверенных источников
Botensilimab + balstilimab showed no CRC recurrences in resectable colon cancer, phase II NEST trial shows cancerletter.com
Missing routine cancer screening tests can lead to critical delays in diagnosis and treatment. A new study by researchers at the American Cancer Society (ACS) shows that millions of U.S. adults with disabilities who are eligible for breast, cervical and colorectal cancer screening have lower testing rates than people…
В Подмосковье почти на 10% выросла выявляемость колоректального рака Radio1.ru
В Подмосковье почти на 10% выросла выявляемость колоректального рака Radio1.ru
Researchers have developed a blood-based assay that could help identify individuals with precursor lesions for colorectal cancer, a known limitation of many blood-based screening tests. The assay, known as DENEB, detected 81% of advanced adenomas, as well as 91% of CRC overall and 92% of stage I to III cancers…
:og(360tv.ru,%27%D0%92%D1%8B%D1%8F%D0%B2%D0%BB%D1%8F%D0%B5%D0%BC%D0%BE%D1%81%D1%82%D1%8C%20%D0%BA%D0%BE%D0%BB%D0%BE%D1%80%D0%B5%D0%BA%D1%82%D0%B0%D0%BB%D1%8C%D0%BD%D0%BE%D0%B3%D0%BE%20%D1%80%D0%B0%D0%BA%D0%B0%20%D0%B2%C2%A0%D0%9F%D0%BE%D0%B4%D0%BC%D0%BE%D1%81%D0%BA%D0%BE%D0%B2%D1%8C%D0%B5%20%D0%B2%D1%8B%D1%80%D0%BE%D1%81%D0%BB%D0%B0%20%D0%BD%D0%B0%C2%A09,7%25%27):format(jpg)/aHR0cHM6Ly90ZXJtaW5hbC5tb3NyZWcucnUvbWVkaWEvbWVkaWEvaW1hZ2UvMjAyNi85L3Bob3RvLTIwMjYtMDktMTEtMTItNDYtMDEuanBn.jpg)
Выявляемость колоректального рака в Подмосковье выросла на 9,7% 360.ru
FDA Clears Clinical Trial Using CAR T-Cells to Fight Colorectal Cancer University of Colorado Anschutz
FDA Clears CU Anschutz Clinical Trial Using Engineered Immune Cells to Fight Colorectal Cancer Yahoo Finance Singapore
FDA Clears CU Anschutz Clinical Trial Using Engineered Immune Cells to Fight Colorectal Cancer PR Newswire
The American Cancer Society study stresses the need to address barriers for individuals with disabilities to improve cancer screening rates
“Cancer Melted Away”: Immunotherapy Delivers Striking Results in Bowel Cancer Trial SciTechDaily
SOTIO Doses First Patient in Phase 1/2 CADENCIA-01 Clinical Trial of SOT109, a CDH17-Targeting ADC for Colorectal Cancer BioSpace
Исследование: Helicobacter pylori может быть связана с 22% случаев колоректального рака Vademec.ru
Исследование: Helicobacter pylori может быть связана с 22% случаев колоректального рака Vademec.ru
IFN-β hijacks MEK signaling to promote dormant, death-evading colorectal cancer cells Bioengineer.org